Anzeige
Mehr »
Login
Montag, 17.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Suchen Sie auch nach Fosterville South (A2QJKK)? Hier gibt´s News!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PK7M ISIN: SE0012673291 Ticker-Symbol: MN2 
Frankfurt
17.05.21
08:08 Uhr
7,540 Euro
-0,020
-0,26 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MENTICE AB Chart 1 Jahr
5-Tage-Chart
MENTICE AB 5-Tage-Chart
PR Newswire
302 Leser
Artikel bewerten:
(1)

Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions

- Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios

STOCKHOLM, May 21, 2020 /PRNewswire/ -- Mentice AB (STO: MNTC), a world leader in high-fidelity endovascular simulation introduces Coronary Advanced for select VIST platforms. Following the introduction of Coronary Essentials and Coronary Intermediate, Coronary Advanced is the most sophisticated solution, specifically designed for advanced fellows and attending IC's.

The solution was designed to take full advantage of the premium version of Mentice's seventh generation VIST platform, the VIST G7+. This new platform brings simulation to the next level of realism by enabling simultaneous manipulation of multiple devices to support realistic treatment of bifurcation lesions and other dual-device techniques.

"Coronary bifurcations represent some of the most challenging lesions for interventional cardiologists. The lesions are most likely complex and the different solutions for bifurcation stenting are often technically demanding with patients facing high risk of complications if interventions are sub-optimally performed," said Dr. Jens Flensted Lassen, Professor at Odense University Hospital (DK). "The operator is central to obtaining the best possible technical stenting solution for the patient with training, development, and proficiency of procedural skills being mandatory for all operators. It is highly recommended that all operators treating bifurcations in the coronary tree integrate high-fidelity endovascular simulation such as the VIST G7+ platform into their practice allowing them to mimic real-life scenarios in bifurcation stenting and enabling them to explore technical issues while applying tips and tricks they have accumulated over years of practice," Dr. Lassen continued.

Coronary Advanced offers the following capabilities:

  • Leverages the VIST G7+ platform supporting simultaneous control of devices
  • Includes step-by-step expert guidance based on EBC recommendations for bifurcation stenting
  • Supports a variety of techniques involved in bifurcation stenting such as kissing-balloon, wire jailing, POT, T-Stenting, TAP, Culotte, and DK-Crush
  • Supports subintimal and retrograde techniques for treating challenging CTOs
  • Offers advanced metrics and benchmarking to optimize training and identifying areas of improvement
  • Includes iPad proctor app for customizing scenarios and remotely triggering complications in real-time during the intervention

Coronary Advanced takes cardiology skills training to the next level, offering a solution for exploring complications and new techniques to experienced fellows and attending physicians," said Edward Fält, Vice President of Products, Mentice. "Interventional cardiologists now have access to a solution that provides a life-like environment helping them train, develop new skills, and retain proficiency for some of the most challenging situations. And with the ability to use Coronary Advanced on the G7+ platform, treatment of complex bifurcation lesions in a simulated environment is now more realistic than ever."

To learn more about the Coronary Advanced software solution, Mentice will hold an online webinar on May 28th at 15:00 Central European Time with Dominic Steffel, Senior Product Manager, Mentice, joined by co-host Dr. Jens Flensted Lassen, Professor at Odense University Hospital (DK) presenting the unique software capabilities. Please pre-register at - www.mentice.com/coronary-advanced

Contact for journalists:
Edward Fält
VP of Product Management
edward.faelt@mentice.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/mentice-ab/r/mentice-expands-its-coronary-product-portfolio-with-an-advanced-software-solution-for-coronary-inter,c3117364

MENTICE-Aktie komplett kostenlos handeln - auf Smartbroker.de
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.